These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30793560)

  • 41. Isolated exon 8 deletion in type 1 spinal muscular atrophy with bilateral optic atrophy: unusual genetic mutation leading to unusual manifestation?
    Maiti D; Bhattacharya M; Yadav S
    J Postgrad Med; 2012; 58(4):294-5. PubMed ID: 23298926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried blood-spot DNA.
    Ar Rochmah M; Harahap NIF; Niba ETE; Nakanishi K; Awano H; Morioka I; Iijima K; Saito T; Saito K; Lai PS; Takeshima Y; Takeuchi A; Bouike Y; Okamoto M; Nishio H; Shinohara M
    Brain Dev; 2017 Oct; 39(9):774-782. PubMed ID: 28522225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials.
    Zanetta C; Nizzardo M; Simone C; Monguzzi E; Bresolin N; Comi GP; Corti S
    Clin Ther; 2014 Jan; 36(1):128-40. PubMed ID: 24360800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutics development for spinal muscular atrophy.
    Sumner CJ
    NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular analysis of the neuronal apoptosis inhibitory protein gene in families with spinal muscular atrophy.
    Salahshourifar I; Shafeghati Y; Golkar Z; Najmabadi H
    Arch Iran Med; 2007 Oct; 10(4):509-13. PubMed ID: 17903057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infantile olivopontocerebellar atrophy with spinal muscular atrophy (infantile OPCA + SMA).
    Chou SM; Gilbert EF; Chun RW; Laxova R; Tuffli GA; Sufit RL; Krassikot N
    Clin Neuropathol; 1990; 9(1):21-32. PubMed ID: 2407400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Molecular genetic diagnosis and deletion analysis in Type I-III spinal muscular atrophy].
    Spiegel R; Hagmann A; Boltshauser E; Moser H
    Schweiz Med Wochenschr; 1996 May; 126(21):907-14. PubMed ID: 8693311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A study of infantile motor neuron disease with neurofilament and ubiquitin immunocytochemistry.
    Lee S; Park YD; Yen SH; Ksiezak-Reding H; Goldman JE; Dickson DW
    Neuropediatrics; 1989 May; 20(2):107-11. PubMed ID: 2544822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spinal Muscular Atrophy: Past, Present, and Future.
    Ross LF; Kwon JM
    Neoreviews; 2019 Aug; 20(8):e437-e451. PubMed ID: 31371553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuronal death is enhanced and begins during foetal development in type I spinal muscular atrophy spinal cord.
    Soler-Botija C; Ferrer I; Gich I; Baiget M; Tizzano EF
    Brain; 2002 Jul; 125(Pt 7):1624-34. PubMed ID: 12077011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Grohmann K; Varon R; Stolz P; Schuelke M; Janetzki C; Bertini E; Bushby K; Muntoni F; Ouvrier R; Van Maldergem L; Goemans NM; Lochmüller H; Eichholz S; Adams C; Bosch F; Grattan-Smith P; Navarro C; Neitzel H; Polster T; Topaloğlu H; Steglich C; Guenther UP; Zerres K; Rudnik-Schöneborn S; Hübner C
    Ann Neurol; 2003 Dec; 54(6):719-24. PubMed ID: 14681881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spinal muscular atrophy with progressive myoclonic epilepsy: report of new cases and review of the literature.
    Haliloglu G; Chattopadhyay A; Skorodis L; Manzur A; Mercuri E; Talim B; Akçören Z; Renda Y; Muntoni F; Topaloğlu H
    Neuropediatrics; 2002 Dec; 33(6):314-9. PubMed ID: 12571787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism.
    Fidziańska A; Goebel HH; Warlo I
    Brain; 1990 Apr; 113 ( Pt 2)():433-45. PubMed ID: 2328412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac defects contribute to the pathology of spinal muscular atrophy models.
    Shababi M; Habibi J; Yang HT; Vale SM; Sewell WA; Lorson CL
    Hum Mol Genet; 2010 Oct; 19(20):4059-71. PubMed ID: 20696672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Nerve growth factors: a hypothesis on their role in the pathogenesis of infantile spinal amyotrophies].
    Henderson CE; Fardeau M
    Rev Neurol (Paris); 1988; 144(11):730-6. PubMed ID: 3231962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Werdnig-Hoffmann's infantile progressive muscular atrophy; clinical aspects, pathology, heredity, and relation to Oppenheim's amyotonia congenita and other morbid conditions with laxity of the joints or muscles in children].
    BRANDT S
    Nord Med; 1950 Sep; 44(37):1499. PubMed ID: 14806955
    [No Abstract]   [Full Text] [Related]  

  • 58. Infantile spinal muscular atrophy (SMA) and multiple congenital bone fractures in sibs: a lethal new syndrome.
    Borochowitz Z; Glick B; Blazer S
    J Med Genet; 1991 May; 28(5):345-8. PubMed ID: 1865475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spinal muscular atrophy due to double gene conversion event.
    Maamouri W; Hammer MB; Bouhlel Y; Souilem S; Khmiri N; Nehdi H; Hentati F; Amouri R
    Int J Neurosci; 2011 Feb; 121(2):107-11. PubMed ID: 21047176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical trials in spinal muscular atrophy.
    Darras BT; Kang PB
    Curr Opin Pediatr; 2007 Dec; 19(6):675-9. PubMed ID: 18025935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.